New transplant recipe shows promise for AML patients in remission
NCT ID NCT07155382
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study looked at 98 adults with acute myeloid leukemia (AML) in their first remission who received a stem cell transplant from a matched sibling, matched unrelated donor, or half-matched family donor. All patients got the same chemotherapy before transplant. The goal was to see how well the transplant worked and track outcomes like relapse, graft-versus-host disease, and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.